Published in Cancer Weekly, April 26th, 2005
According to a study from Italy, "DNA vaccination with the idiotype (Id) of tumor B-cell membrane immunoglobulins (Ig) is a validated strategy to induce tumor protection to several mouse lymphomas. The relative contribution of anti-Id antibodies and T lymphocytes to tumor rejection is still debated. Previous studies in the BCL1 lymphoma model showed that scFv DNA immunization induces a polyclonal antibody response restricted to conformational epitopes formed by the parental VL /VH association. We implemented a system based on this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.